Also listed on Translate Bio, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Sep 14, 2034 · High confidence
20-year base term ends May 16, 2033
Held by Translate Bio Ma, Inc.
Filed May 18, 2020 as application 16/876,271 · Granted Oct 17, 2023
Base term plus 486 days of patent term adjustment (USPTO delay)
Today
2013
2034
Clock starts
May 16, 2013
May 16, 2013
Term ends
Sep 14, 2034
Sep 14, 2034
Granted
Oct 17, 2023
Oct 17, 2023
base term
patent term adjustment
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
486
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
26
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 486 days past its 20-year base term on prosecution delay. 0 of 2 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 16, 2013, when application PCT/US2013/041394, the earliest non-provisional in its chain, was filed (this one was filed May 18, 2020) | May 16, 2033 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +486 days, USPTO patent term adjustment record | Sep 14, 2034 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Sep 14, 2034 | High confidence |
This family
| Application PCT/US2013/041440 | PCT application no patent term | no patent term |
| Application PCT/US2013/041452 | PCT application no patent term | no patent term |
| Application PCT/US2013/041382 | PCT application no patent term | no patent term |
| Application PCT/US2013/041381 | PCT application no patent term | no patent term |
| Application PCT/US2013/041455 | PCT application no patent term | no patent term |
| Application PCT/US2013/041389 | PCT application no patent term | no patent term |
| Application PCT/US2013/041385 | PCT application no patent term | no patent term |
| Application PCT/US2013/041394 | PCT application no patent term | no patent term |
8 of 26 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 17, 2020 Reel 53511, frame 442 | Krieg, Arthur M.; Subramanian, Romesh; McSwiggen, James | Rana Therapeutics, Inc. | Assignment of Assignor's Interest |
| Aug 17, 2020 Reel 53511, frame 465 | Lee, Jeannie T. | Howard Hughes Medical Institute | Assignment of Assignor's Interest |
| Aug 17, 2020 Reel 53511, frame 469 | Howard Hughes Medical Institute | The General Hospital Corporation D/B/A/ Massachusetts General Hospital | Assignment of Assignor's Interest |
| Feb 26, 2021 Reel 55419, frame 935 | Translate Bio Ma, Inc. | The General Hospital Corporation | Assignment of Assignor's Interest |
| Apr 27, 2021 Reel 56062, frame 179 | Rana Therapeutics, Inc. | Rana Development, Inc. | Change of Name |
| Apr 27, 2021 Reel 56062, frame 195 | Rana Development, Inc. | Translate Bio Ma, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Sep 2034
Term ends Sep 14, 2034. Maintenance fees still fall due before then
Note
The 486 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
2
later US patents cite this one
That is above the median of utility patents granted in 2023 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.